Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Immunoglobulins"" wg kryterium: Temat


Starter badań:

Tytuł :
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Autorzy :
Rodríguez de la Concepción ML; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.
Ainsua-Enrich E; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.
Reynaga E; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Ávila-Nieto C; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.
Santos JR; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Roure S; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Mateu L; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.; Universitat Autonoma de Barcelona, Cerdanyola Del Vallès, Spain.; CIBERes: Centro de investigaciones en Red de Enfermedades Respiratorias Del Instituto Carlos III, Madrid, Spain.
Paredes R; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Puig J; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Jimenez JM; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Izquierdo-Useros N; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.
Clotet B; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.; Chair in Infectious Diseases and Immunity, Centre for Health and Social Care Research (CESS), Faculty of Medicine. University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Universitat Autonoma de Barcelona, Cerdanyola Del Vallès, Spain.; CIBERes: Centro de investigaciones en Red de Enfermedades Respiratorias Del Instituto Carlos III, Madrid, Spain.
Pedro-Botet ML; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.; Universitat Autonoma de Barcelona, Cerdanyola Del Vallès, Spain.; CIBERes: Centro de investigaciones en Red de Enfermedades Respiratorias Del Instituto Carlos III, Madrid, Spain.
Carrillo J; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain .
Pokaż więcej
Źródło :
Life science alliance [Life Sci Alliance] 2021 Jul 28; Vol. 4 (9). Date of Electronic Publication: 2021 Jul 28 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*therapy
Immunoglobulins, Intravenous/*therapeutic use
Administration, Intravenous ; Adult ; Aged ; Biomarkers/blood ; COVID-19/blood ; COVID-19/immunology ; COVID-19/virology ; Chemokines/blood ; Cytokines/blood ; Female ; Humans ; Immunity/immunology ; Immunoglobulins/immunology ; Immunoglobulins/therapeutic use ; Immunoglobulins, Intravenous/immunology ; Inflammation/blood ; Inflammation/therapy ; Inflammation/virology ; Male ; Middle Aged ; SARS-CoV-2/isolation & purification
Czasopismo naukowe
Tytuł :
The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children.
Autorzy :
Lee JH; Department of Pediatrics, College of Medicine, Chungbuk National University, Cheongju, Korea.; Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Korea.
Han HS; Department of Pediatrics, College of Medicine, Chungbuk National University, Cheongju, Korea.; Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Korea.
Lee JK; Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Korea.; Department of Infection Control and Prevention, Chungbuk National University Hospital, Cheongju, Korea. .
Pokaż więcej
Źródło :
Journal of Korean medical science [J Korean Med Sci] 2021 Jan 11; Vol. 36 (2), pp. e17. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Systemic Inflammatory Response Syndrome*/diagnosis
Systemic Inflammatory Response Syndrome*/pathology
Systemic Inflammatory Response Syndrome*/therapy
COVID-19/*pathology
COVID-19/*therapy
Immunoglobulins, Intravenous/*therapeutic use
Antibodies, Viral/therapeutic use ; COVID-19/diagnosis ; Child ; Humans ; Immunization, Passive/methods ; Immunoglobulins/administration & dosage ; Immunoglobulins/therapeutic use ; Male ; Republic of Korea ; SARS-CoV-2/immunology ; Treatment Outcome
SCR Disease Name :
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Tytuł :
Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin.
Autorzy :
Esmaeilzadeh H; Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Askarisarvestani A; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Hosseini N; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Samimi S; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Shafiei A; Division of Allergy and Clinical Immunology, Department of Pediatrics, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mahdaviani SA; Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Eslami N; Allergy and Clinical immunology Dept, Mofid Children Hospital, , Shahid Beheshti University of Medical Sciences, Tehran, , Iran.
Chavoshzadeh Z; Allergy and Clinical immunology Dept, Mofid Children Hospital, , Shahid Beheshti University of Medical Sciences, Tehran, , Iran.
Fallahi M; Allergy and Clinical immunology Dept, Mofid Children Hospital, , Shahid Beheshti University of Medical Sciences, Tehran, , Iran.
Khakbazanfard N; Allergy and Clinical immunology Dept, Mofid Children Hospital, , Shahid Beheshti University of Medical Sciences, Tehran, , Iran.
Shabestari MS; Department of Immunology and Allergy, Tabriz University of Medical Sciences, Tabriz, Iran.
Aleyasin S; Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Nabavizadeh SH; Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Cheraghi T; Department of Pediatrics, 17th Shahrivar Children's Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Kalantari A; Department of Immunology and Allergy, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ahmadiafshar A; Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
Safari M; Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.
Eslamian MH; Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.
Molatefi R; Department of Pediatrics, Bo-Ali children's Hospital of Ardabil University of Medical Sciences, Ardabil, Iran.
Shirkani A; Allergy and Clinical Immunology Department, Bushehr University of Medical Science, School of Medicine, Bushehr, Iran.
Heidarzadeh Arani M; Pediatric Department, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Tavakol M; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Bemanian MH; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Arshi S; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Nabavi M; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Shokri S; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Shahhosseini B; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Mortazavi N; Department of Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Nakhaei P; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Nazari F; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Fallahpour M; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Ahanchian H; Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Moazzen N; Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Khoshkhui M; Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Motlagh AV; Department of Pediatrics, North Khorasan University of Medical Sciences, Bojnurd. Iran.
Aghamohammadi A; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Abolhassani H; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Division of Clinical Immunology, Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden; Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Yazdani R; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Rezaei N; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: .
Pokaż więcej
Źródło :
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2021 Sep; Vol. 230, pp. 108826. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunoglobulins, Intravenous/*adverse effects
Immunologic Deficiency Syndromes/*genetics
Immunologic Deficiency Syndromes/*therapy
Adolescent ; Adult ; Agammaglobulinemia/genetics ; Agammaglobulinemia/immunology ; Agammaglobulinemia/therapy ; Aged ; Ataxia Telangiectasia/genetics ; Ataxia Telangiectasia/immunology ; Ataxia Telangiectasia/therapy ; Child ; Child, Preschool ; Cohort Studies ; Common Variable Immunodeficiency/genetics ; Common Variable Immunodeficiency/immunology ; Common Variable Immunodeficiency/therapy ; Female ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Immunologic Deficiency Syndromes/immunology ; Infant ; Infusions, Intravenous ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease.
Autorzy :
He L; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Liu F; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Yan W; Department of Clinical Epidemiology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Huang M; Cardiovascular Department, Shanghai Children's Hospital of Shanghai Jiaotong University, Shanghai, China.
Huang M; Cardiovascular Department, Shanghai Children's Medical Center of Shanghai Jiaotong University, Shanghai, China.
Xie L; Cardiovascular Department, Shanghai Children's Hospital of Shanghai Jiaotong University, Shanghai, China.
Guo Y; Cardiovascular Department, Shanghai Children's Medical Center of Shanghai Jiaotong University, Shanghai, China.
Xu X; Cardiovascular Department, Shanghai Children's Medical Center of Shanghai Jiaotong University, Shanghai, China.
Chu C; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Wu L; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Liang X; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Sun S; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Wang F; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Zhao L; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Zhao Q; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Ma X; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Xie L; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Huang G; Pediatric Heart Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Pokaż więcej
Źródło :
Pediatrics international : official journal of the Japan Pediatric Society [Pediatr Int] 2021 Jul; Vol. 63 (7), pp. 757-763. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Immunoglobulins, Intravenous*/therapeutic use
Mucocutaneous Lymph Node Syndrome*/drug therapy
Aspirin ; Fever ; Humans ; Infant
Czasopismo naukowe
Tytuł :
A single center experience of intravenous immunoglobulin treatment in Covid-19.
Autorzy :
Omma A; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey.
Erden A; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey.
Armağan B; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey.
Güven SC; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey. Electronic address: .
Karakaş Ö; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey.
Şahiner ES; Ministry of Health Ankara City Hospital, Clinic of Internal Medicine, Ankara 06800, Turkey.
Erdem D; University of Health Sciences, School of Medicine, Ankara City Hospital, Department of Anesthesia and Resuscitation, Ankara 06800, Turkey.
İzdeş S; Yıldırım Beyazıt University, School of Medicine, Department of Anesthesiology and Reanimation-Critical Care, Ankara 06800, Turkey.
Ateş İ; University of Health Sciences, School of Medicine, Ankara City Hospital, Department of Internal Medicine, Ankara 06800, Turkey.
Küçükşahin O; Yıldırım Beyazıt University, School of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara 06800, Turkey.
Pokaż więcej
Źródło :
International immunopharmacology [Int Immunopharmacol] 2021 Sep; Vol. 98, pp. 107891. Date of Electronic Publication: 2021 Jun 14.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19/*drug therapy
Immunoglobulins, Intravenous/*administration & dosage
Administration, Intravenous ; Adult ; Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/mortality ; COVID-19/virology ; Cross-Sectional Studies ; Female ; Humans ; Immunoglobulins, Intravenous/adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; Turkey
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Intravenous immunoglobulin as the rescue treatment in NMOSD patients.
Autorzy :
Lin J; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xue B; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Zhu R; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Pan J; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Li J; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lin Y; Department of Neurology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Li X; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. .
Xia J; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. .
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 Sep; Vol. 42 (9), pp. 3857-3863. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article
MeSH Terms :
Immunoglobulins, Intravenous*/therapeutic use
Neuromyelitis Optica*/drug therapy
Aquaporin 4 ; Autoantibodies ; Humans ; Methylprednisolone/therapeutic use ; Recurrence ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Guillain-Barré syndrome as the first presentation of human immunodeficiency virus infection.
Autorzy :
Lopes M; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. .
Marques P; Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Silva B; Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Cruz G; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Serra JE; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Ferreira E; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Alves H; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
da Cunha JS; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Pokaż więcej
Źródło :
BMC neurology [BMC Neurol] 2021 Aug 18; Vol. 21 (1), pp. 321. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Primary Dysautonomias*
Adrenal Cortex Hormones/*therapeutic use
Guillain-Barre Syndrome/*complications
HIV Infections/*drug therapy
Immunoglobulins, Intravenous/*therapeutic use
Muscle Weakness/*etiology
Adrenal Cortex Hormones/administration & dosage ; Guillain-Barre Syndrome/diagnosis ; Guillain-Barre Syndrome/drug therapy ; HIV Infections/complications ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Male ; Middle Aged ; Muscle Weakness/drug therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Thromboembolic complications following intravenous immunoglobulin therapy in immune-mediated neurological disorders.
Autorzy :
Chun W; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea.
Kim Y; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea.
Park SH; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea; Department of Critical Care Medicine, Inha University Hospital, Incheon, Republic of Korea.
Choi SJ; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea; Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2021 Aug; Vol. 90, pp. 311-316. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Immunization, Passive/*adverse effects
Immunoglobulins, Intravenous/*adverse effects
Nervous System Diseases/*complications
Nervous System Diseases/*therapy
Thromboembolism/*complications
Aged, 80 and over ; Critical Illness ; Female ; Guillain-Barre Syndrome/complications ; Guillain-Barre Syndrome/therapy ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Ischemic Stroke/etiology ; Male ; Middle Aged ; Myasthenia Gravis/complications ; Myasthenia Gravis/therapy ; Pulmonary Embolism/etiology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Effects of compaction and storage conditions on stability of intravenous immunoglobulin - Implication on developing oral tablets of biologics.
Autorzy :
Lu Y; Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MN 21201, United States.
Wang C; Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, United States.
Jiang B; Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MN 21201, United States.
Sun CC; Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address: .
Hoag SW; Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MN 21201, United States. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2021 Jul 15; Vol. 604, pp. 120737. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article
MeSH Terms :
Biological Products*
Immunoglobulins, Intravenous*
Chromatography, Gel ; Circular Dichroism ; Drug Stability ; Humans ; Spectroscopy, Fourier Transform Infrared ; Tablets
Czasopismo naukowe
Tytuł :
The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro.
Autorzy :
Lyu J; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China; Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Bao L; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Shen X; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Yan C; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Zhang C; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Wei W; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Yang Y; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Li J; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Dong J; Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Xiao L; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Zhou X; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address: .
Li Y; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address: .
Pokaż więcej
Źródło :
International immunopharmacology [Int Immunopharmacol] 2021 Jul; Vol. 96, pp. 107797. Date of Electronic Publication: 2021 May 19.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies/*immunology
Antiviral Agents/*immunology
COVID-19/*immunology
Immunoglobulins/*immunology
Immunologic Factors/*immunology
Interferon-gamma/*metabolism
SARS-CoV-2/*immunology
Animals ; Antibodies/pharmacology ; Antiviral Agents/pharmacology ; COVID-19/therapy ; Chickens ; Drug Development ; Egg Yolk/chemistry ; Egg Yolk/metabolism ; Humans ; Immunity ; Immunoglobulins/pharmacology ; Immunologic Factors/pharmacology ; Immunomodulation ; In Vitro Techniques ; Nucleocapsid Proteins/immunology ; Nucleocapsid Proteins/metabolism ; SARS-CoV-2/metabolism
Czasopismo naukowe
Tytuł :
Meflin defines mesenchymal stem cells and/or their early progenitors with multilineage differentiation capacity.
Autorzy :
Hara A; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kato K; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ishihara T; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kobayashi H; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Asai N; Department of Pathology, Fujita Health University, Toyoake, Japan.
Mii S; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shiraki Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Miyai Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ando R; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Mizutani Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Iida T; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takefuji M; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Murohara T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takahashi M; International Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan.
Enomoto A; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło :
Genes to cells : devoted to molecular & cellular mechanisms [Genes Cells] 2021 Jul; Vol. 26 (7), pp. 495-512. Date of Electronic Publication: 2021 May 17.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Differentiation*
Cell Lineage*
Immunoglobulins/*metabolism
Mesenchymal Stem Cells/*metabolism
Adipocytes/cytology ; Adipocytes/metabolism ; Animals ; Chondrocytes/cytology ; Chondrocytes/metabolism ; Immunoglobulins/genetics ; Mesenchymal Stem Cells/cytology ; Mice ; Mice, Inbred C57BL ; Muscle Cells/cytology ; Muscle Cells/metabolism ; Osteocytes/cytology ; Osteocytes/metabolism
Czasopismo naukowe
Tytuł :
Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response.
Autorzy :
Rambabu N; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, F-75006 Paris, France.
Mathew MJ; École D'ingénieur Généraliste en Informatique et Technologies du Numérique, 30-32 Avenue de la République, F-94800 Villejuif, France.
Kaveri SV; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, F-75006 Paris, France.
Bayry J; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, F-75006 Paris, France; Indian Institute of Technology Palakkad, Palakkad 678623, India. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2021 Jul; Vol. 20 (7), pp. 102850. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunoglobulins, Intravenous*/therapeutic use
Mucocutaneous Lymph Node Syndrome*/diagnosis
Mucocutaneous Lymph Node Syndrome*/drug therapy
Mucocutaneous Lymph Node Syndrome*/genetics
Biomarkers ; Humans ; Infant ; Retrospective Studies ; Transcriptome
Czasopismo naukowe
Tytuł :
Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
Autorzy :
Seidel V; Department of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany. .
Hackelöer M; Department of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
Rancourt RC; Division of 'Experimental Obstetrics', Clinic of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Virchow-Klinikum, Berlin, Germany.
Henrich W; Department of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
Siedentopf JP; Department of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Dec; Vol. 302 (6), pp. 1353-1359. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Amniotic Fluid/*virology
Cytomegalovirus/*immunology
Cytomegalovirus Infections/*diagnosis
Cytomegalovirus Infections/*transmission
Immunoglobulins/*administration & dosage
Infectious Disease Transmission, Vertical/*prevention & control
Pregnancy Complications, Infectious/*diagnosis
Pregnancy Complications, Infectious/*virology
Adult ; Antibodies, Viral ; Cohort Studies ; Cytomegalovirus Infections/drug therapy ; Cytomegalovirus Infections/prevention & control ; Female ; Fetal Diseases/diagnosis ; Humans ; Immunoglobulins/therapeutic use ; Immunoglobulins, Intravenous ; Infant ; Infant, Newborn ; Pregnancy ; Pregnancy Complications, Infectious/drug therapy ; Pregnancy Complications, Infectious/prevention & control ; Pregnancy Outcome/epidemiology ; Prenatal Care ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion.
Autorzy :
Perreault S; Department of Pharmacy, Yale New Haven Health, New Haven, CT, USA.
Schiffer M; Department of Pharmacy, Yale New Haven Health, New Haven, CT, USA.
Clinchy-Jarmoszko V; Department of Nursing, Yale New Haven Health, New Haven, CT, USA.
Bocchetta N; Department of Nursing, Yale New Haven Health, New Haven, CT, USA.
Barbarotta L; Department of Nursing, Yale New Haven Health, New Haven, CT, USA.
Abdelghany O; Department of Pharmacy, Yale New Haven Health, New Haven, CT, USA.
Foss F; Department of Hematology, Yale School of Medicine, New Haven, CT, and Yale New Haven Health, New Haven, CT, USA.
Huntington S; Department of Hematology, Yale School of Medicine, New Haven, CT, and Yale New Haven Health, New Haven, CT, USA.
Seropian S; Department of Hematology, Yale School of Medicine, New Haven, CT, and Yale New Haven Health, New Haven, CT, USA.
Isufi I; Department of Hematology, Yale School of Medicine, New Haven, CT, and Yale New Haven Health, New Haven, CT, USA.
Pokaż więcej
Źródło :
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2021 Jun 07; Vol. 78 (12), pp. 1112-1117.
Typ publikacji :
Journal Article
MeSH Terms :
Immunocompromised Host*
COVID-19/*prevention & control
Home Care Services/*organization & administration
Immunoglobulins, Intravenous/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Ambulatory Care Facilities/organization & administration ; Female ; Humans ; Immunoglobulins, Intravenous/adverse effects ; Immunoglobulins, Intravenous/economics ; Male ; Middle Aged ; Patient Care Team ; Patient Satisfaction ; SARS-CoV-2 ; United States
Czasopismo naukowe
Tytuł :
On the use of intravenous immunoglobulins for the treatment of the antiphospholipid syndrome - A systematic review and meta-analysis.
Autorzy :
Lalmahomed TA; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Walter IJ; Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
Lely AT; Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
Bloemenkamp KWM; Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
Kooiman J; Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
Limper M; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2021 Jun; Vol. 20 (6), pp. 102828. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Letter; Meta-Analysis; Systematic Review
MeSH Terms :
Antiphospholipid Syndrome*/drug therapy
Immunoglobulins, Intravenous*/therapeutic use
Antibodies, Antiphospholipid ; Humans ; beta 2-Glycoprotein I
Raport
Tytuł :
Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 - A theoretical perspective.
Autorzy :
Yaqinuddin A; Alfaisal University, Riyadh, Saudi Arabia.
Ambia AR; Alfaisal University, Riyadh, Saudi Arabia.
Elgazzar TA; Alfaisal University, Riyadh, Saudi Arabia.
AlSaud MBM; Alfaisal University, Riyadh, Saudi Arabia.
Kashir J; Alfaisal University, Riyadh, Saudi Arabia; Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address: .
Pokaż więcej
Źródło :
Medical hypotheses [Med Hypotheses] 2021 Jun; Vol. 151, pp. 110592. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Immunoglobulins, Intravenous*
Aged ; Humans ; Inflammation ; RNA, Viral ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap.
Autorzy :
McShan AC; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Devlin CA; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL, USA.
Morozov GI; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Overall SA; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA, USA.
Moschidi D; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA, USA.
Akella N; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL, USA.
Procko E; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL, USA. .
Sgourakis NG; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. .; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 May 26; Vol. 12 (1), pp. 3174. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigen Presentation*
Histocompatibility Antigens Class I/*metabolism
Immunoglobulins/*metabolism
Membrane Proteins/*metabolism
Molecular Chaperones/*metabolism
Antigens/metabolism ; Cryoelectron Microscopy ; Crystallography, X-Ray ; Gene Knockout Techniques ; HEK293 Cells ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/isolation & purification ; Histocompatibility Antigens Class I/ultrastructure ; Humans ; Immunoglobulins/genetics ; Immunoglobulins/isolation & purification ; Immunoglobulins/ultrastructure ; Ligands ; Membrane Proteins/genetics ; Membrane Proteins/isolation & purification ; Membrane Proteins/ultrastructure ; Membrane Transport Proteins/genetics ; Membrane Transport Proteins/metabolism ; Molecular Chaperones/genetics ; Molecular Chaperones/ultrastructure ; Molecular Dynamics Simulation ; Mutagenesis, Site-Directed ; Mutation ; Peptide Library ; Protein Binding/genetics ; Protein Binding/immunology ; Recombinant Proteins/genetics ; Recombinant Proteins/isolation & purification ; Recombinant Proteins/metabolism ; Recombinant Proteins/ultrastructure
Czasopismo naukowe
Tytuł :
A novel ITAM-containing immunoglobulin superfamily receptor involved in lamprey VLRB+ lymphocyte immune response.
Autorzy :
Liu X; Lamprey Research Center, College of Life Science, Liaoning Normal University, Dalian 116081, China.; Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.
Wang S; Lamprey Research Center, College of Life Science, Liaoning Normal University, Dalian 116081, China.; Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.
Ma Q; Lamprey Research Center, College of Life Science, Liaoning Normal University, Dalian 116081, China.; Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.
Liang W; Lamprey Research Center, College of Life Science, Liaoning Normal University, Dalian 116081, China.; Fujin No.1 Middle School of Heilongjiang, Fujin 156100, China.
Li J; Lamprey Research Center, College of Life Science, Liaoning Normal University, Dalian 116081, China.; Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.
Zhu T; Lamprey Research Center, College of Life Science, Liaoning Normal University, Dalian 116081, China.; Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.
Li Q; Lamprey Research Center, College of Life Science, Liaoning Normal University, Dalian 116081, China.; Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.
Han Y; Lamprey Research Center, College of Life Science, Liaoning Normal University, Dalian 116081, China.; Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.
Pokaż więcej
Źródło :
Acta biochimica et biophysica Sinica [Acta Biochim Biophys Sin (Shanghai)] 2021 May 21; Vol. 53 (6), pp. 800-803.
Typ publikacji :
Journal Article
MeSH Terms :
Fish Proteins*/genetics
Fish Proteins*/immunology
Immunity, Cellular*
Immunoglobulins*/genetics
Immunoglobulins*/immunology
Lampreys*/genetics
Lampreys*/immunology
Receptors, Immunologic*/genetics
Receptors, Immunologic*/immunology
Lymphocytes/*immunology
Animals
Czasopismo naukowe
Tytuł :
Administration of intravenous immunoglobulin in the treatment of COVID-19: A review of available evidence.
Autorzy :
Moradimajd P; Department of Anesthesia, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Samaee H; Departement of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Sedigh-Maroufi S; Department of Anesthesia, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Kourosh-Aami M; Department of Neuroscience, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohsenzadagan M; Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 May; Vol. 93 (5), pp. 2675-2682. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19/*drug therapy
Immunoglobulins, Intravenous/*administration & dosage
Immunoglobulins, Intravenous/*therapeutic use
Humans ; Immunization, Passive ; Immunoglobulins, Intravenous/adverse effects ; SARS-CoV-2 ; Virus Diseases/drug therapy
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies